Skip to main content

Advertisement

Log in

Mid-term clinical and health-related quality of life outcomes for the Trifecta bioprosthesis

  • Original Article
  • Published:
Indian Journal of Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

Background

The Trifecta valve has been reported to have excellent hemodynamics. Controversy exists on occurrence of patient-prosthesis mismatch (PPM) and data on mid-term outcome is sparse. Health-related quality of life (HRQoL) assessment for the Trifecta valve has not been reported before. The aim of this study was to report the mid-term clinical and HRQoL outcomes in patients undergoing Trifecta valve implantation at our institution.

Methods

In this prospective, observational study, patients undergoing an aortic valve replacement (AVR) using the Trifecta valve were included. Data collection was retrospective from prospectively collected institutional database. Clinical and echocardiographic data were collected prospectively during follow-up. Quality of life was assessed using the Short Form-36 (SF-36) questionnaire.

Results

Forty-seven patients were included in the study of which 9 (19%) were women. Isolated AVR was carried out in 33 (70%) patients. In-hospital mortality and 30-day mortality were 1 (2.1%) and 2 (4.2%), respectively. With a mean indexed effective orifice area (iEOA) 0.96 ± 0.1, none of the patients had severe PPM. Moderate PPM was seen in 19%. The mean follow-up was 3 ± 1.7 years. The 5-year survival estimate was 83.2% in the overall cohort, 81.4% in the isolated and 87.5% in the concomitant procedure group. Freedom from re-operation and structural valve degeneration at 5 years was 95.7% and 97.8%. The mean physical health composite was 69.24 ± 2 and the mean mental health composite was 69.7 ± 25, indicating excellent mental and physical well-being among patients.

Conclusion

The Trifecta valve provides satisfactory hemodynamics, survival and freedom from re-operation and excellent HRQoL at mid-term follow-up.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Dell’Aquila AM, Schlarb D, Schneider SRB, et al. Clinical and echocardiographic outcomes after implantation of the Trifecta aortic bioprosthesis: an initial single-centre experience. Interact Cardiovasc Thorac Surg. 2013;16:112–5.

    Article  Google Scholar 

  2. Kilic A. Structural valve deterioration with the Trifecta: is it the valve or is it implant technique? Ann Thorac Surg. 2020;110:888–9.

    Article  Google Scholar 

  3. Biancari F, Valtola A, Juvonen T, et al. Trifecta versus Perimount Magna Ease aortic valve prostheses. Ann Thorac Surg. 2020;110:879–88.

    Article  Google Scholar 

  4. Kaneyuki D, Nakajima H, Asakura T, et al. Early first-generation Trifecta valve failure: a case series and a review of the literature. Ann Thorac Surg. 2020;109:86–92.

    Article  Google Scholar 

  5. Piñón M, Durán D, Pazos P, Pradas G. Leaflet tear in a Trifecta aortic bioprosthesis 34 months after implantation. Interact Cardiovasc Thorac Surg. 2015;20:281–2.

    Article  Google Scholar 

  6. Hamamoto M, Kobayashi T, Ozawa M, Yoshimura K. Pure cusp tear of Trifecta bioprosthesis 2 years after aortic valve replacement. Ann Thorac Cardiovasc Surg. 2017;23:157–60.

    Article  Google Scholar 

  7. Phan K, Ha H, Phan S, Misfeld M, Di Eusanio M, Yan TD. Early hemodynamic performance of the third generation St Jude Trifecta aortic prosthesis: a systematic review and meta-analysis. J Thorac Cardiovasc Surg. 2015;149:1567–1575.e1–2.

    Article  Google Scholar 

  8. Bavaria JE, Desai ND, Cheung A, et al. The St Jude Medical Trifecta aortic pericardial valve: results from a global, multicenter, prospective clinical study. J Thorac Cardiovasc Surg. 2014;147:590–7.

    Article  Google Scholar 

  9. Mariscalco G, Mariani S, Bichi S, et al. St Jude Medical Trifecta aortic valve: results from a prospective regional multicentre registry. J Cardiothorac Surg. 2015;10:169.

    Article  Google Scholar 

  10. Yadlapati A, Diep J, Barnes MJ, Grogan T, Bethencourt DM, Vorobiof G. Comprehensive hemodynamic comparison and frequency of patient-prosthesis mismatch between the St. Jude Medical Trifecta and Epic Bioprosthetic aortic valves. J Am Soc Echocardiogr. 2014;27:581–9.

    Article  Google Scholar 

  11. Mannam G, Mishra Y, Modi R, et al. Early hemodynamic performance of the TrifectaTM surgical bioprosthesis aortic valve in Indian patient population: 12 month outcomes of the EVEREST post-market study. J Cardiothorac Surg. 2018;13:96.

    Article  Google Scholar 

  12. Kilic A, Sultan I, Navid F, et al. Trifecta aortic bioprosthesis: midterm results in 1,953 patients from a single center. Ann Thorac Surg. 2019;107:1356–62.

    Article  Google Scholar 

  13. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–83.

    Article  Google Scholar 

  14. Jansen Klomp WW, Nierich AP, Peelen LM, et al. Survival and quality of life after surgical aortic valve replacement in octogenarians. J Cardiothorac Surg. 2016;11:38.

    Article  Google Scholar 

  15. Al-Ruzzeh S, Mazrani W, Wray J, et al. The clinical outcome and quality of life following minimally invasive direct coronary artery bypass surgery. J Card Surg. 2004;19:12–6.

    Article  Google Scholar 

  16. Lindsay GM, Hanlon P, Smith LN, Wheatley DJ. Assessment of changes in general health status using the short-form 36 questionnaire 1 year following coronary artery bypass grafting. Eur J Cardiothorac Surg. 2000;18:557–64.

    Article  CAS  Google Scholar 

  17. Laucis NC, Hays RD, Bhattacharyya T. Scoring the SF-36 in orthopaedics: a brief guide. J Bone Joint Surg Am. 2015;97:1628–34.

    Article  Google Scholar 

  18. Blais C, Dumesnil JG, Baillot R, Simard S, Doyle D, Pibarot P. Impact of valve prosthesis-patient mismatch on short-term mortality after aortic valve replacement. Circulation. 2003;108:983–8.

    Article  Google Scholar 

  19. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute Dialysis Quality Initiative workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204–12.

    Article  Google Scholar 

  20. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143:e35–71.

  21. Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739–91.

    Article  Google Scholar 

  22. Hernandez-Vaquero D, Diaz R, Pascual I, et al. The prevalence of patient-prosthesis mismatch can be reduced using the Trifecta aortic prosthesis. Ann Thorac Surg. 2018;105:144–51.

    Article  Google Scholar 

  23. Manabe S, Koinoshita R, Hirayama D, Yuge N, Hirooka K. Hemodynamic performance and incidence of patient–prosthesis mismatch of small-sized Trifecta pericardial aortic valves. Gen Thorac Cardiovasc Surg. 2020;68:938–42.

    Article  Google Scholar 

  24. Mohty D, Malouf JF, Girard SE, et al. Impact of prosthesis-patient mismatch on long-term survival in patients with small St Jude Medical mechanical prostheses in the aortic position. Circulation. 2006;113:420–6.

    Article  Google Scholar 

  25. Del Rizzo DF, Abdoh A, Cartier P, Doty D, Westaby S. Factors affecting left ventricular mass regression after aortic valve replacement with stentless valves. Semin Thorac Cardiovasc Surg. 1999;11:114–20.

    PubMed  Google Scholar 

  26. Bakhtiary F, Schiemann M, Dzemali O, et al. Impact of patient-prosthesis mismatch and aortic valve design on coronary flow reserve after aortic valve replacement. J Am Coll Cardiol. 2007;49:790–6.

    Article  Google Scholar 

  27. Moon MR, Pasque MK, Munfakh NA, et al. Prosthesis-patient mismatch after aortic valve replacement: impact of age and body size on late survival. Ann Thorac Surg. 2006;81:481–8.

    Article  Google Scholar 

  28. Permanyer E, Estigarribia A-J, Ysasi A, Herrero E, Semper O, Llorens R. St. Jude Medical TrifectaTM aortic valve perioperative performance in 200 patients. Interact Cardiovasc Thorac Surg. 2013;17:669–72.

    Article  Google Scholar 

  29. Kalra A, Rehman H, Ramchandani M, et al. Early Trifecta valve failure: report of a cluster of cases from a tertiary care referral center. J Thorac Cardiovasc Surg. 2017;154:1235–40.

    Article  Google Scholar 

  30. Anselmi A, Ruggieri VG, Lelong B, et al. Mid-term durability of the Trifecta bioprosthesis for aortic valve replacement. J Thorac Cardiovasc Surg. 2017;153:21–28.e1.

    Article  Google Scholar 

  31. Dvir D, Leipsic J, Blanke P, et al. Coronary obstruction in transcatheter aortic valve-in-valve implantation: preprocedural evaluation, device selection, protection, and treatment. Circ Cardiovasc Interv. 2015;8:e002079.

    PubMed  Google Scholar 

  32. Valvo R, Costa G, Barbanti M. How to avoid coronary occlusion during TAVR valve-in-valve procedures. Front Cardiovasc Med. 2019;6:168.

    Article  Google Scholar 

  33. Juenger J, Schellberg D, Kraemer S, et al. Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart. 2002;87:235–41.

    Article  CAS  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pradeep Narayan.

Ethics declarations

Ethical approval

Ethical approval was obtained from the institutional ethics committee (EC approval no.: NH-RTIICS/AP/031/2019) on 25 September, 2019.

Informed consent

Obtained from all participants in writing.

Statement of Human and animal rights

The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Purkayastha, B., Khan, M.W., Saha, A. et al. Mid-term clinical and health-related quality of life outcomes for the Trifecta bioprosthesis. Indian J Thorac Cardiovasc Surg 37, 496–505 (2021). https://doi.org/10.1007/s12055-021-01166-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12055-021-01166-5

Keywords

Navigation